-
Study Points to Promising Chemoimmunotherapy Strategy for Aggressive Stage III Non-Small Cell Lung Cancer
04 Jul 2025 12:40 GMT
… III Non-Small Cell Lung Cancer
Publication: JAMA Oncology
Corresponding … III non-small cell lung cancer that is considered … complete response and prolonged event-free survival. Patients with … III non-small cell lung cancer have limited treatment options. …
-
Lung Cancer Risk in Chinese CT-Detected Nodules
03 Jul 2025 06:08 GMT
… considering time-to-event data and accommodating … lung cancer studycomprehensive clinical data analysisearly detection of lung cancerfalse positives in LDCTheavy smokers lung cancer … risk assessmentoverdiagnosis in lung cancerpredictive model for …
-
Mutagenic Forces Shaping Lung Cancer Genomes
03 Jul 2025 02:59 GMT
… facilitating these mutational events. Intriguingly, the … landscape of lung cancerheterogeneity of lung cancerinternational lung cancer studyKRAS … lung cancerregional differences in lung cancer mutationstobacco-free lung cancer casestreatment-naive lung cancer …
-
Dizal's ZEGFROVY® (sunvozertinib) Receives FDA Accelerated Approval as the Only Targeted Oral Treatment for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
03 Jul 2025 01:16 GMT
… or metastatic non-small cell lung cancer (NSCLC) with epidermal growth … increasingly critical factor as lung cancer care shifts toward chronic … related TEAEs (treatment-emergent adverse event) were Grade 1… with respect to future events at the time these …
-
Immunotherapy Plus Chemoradiotherapy Boosts Small-Cell Lung Cancer
02 Jul 2025 22:33 GMT
… Lung Cancer Limited-stage small-cell lung cancer … related adverse events like … small-cell lung cancer. Article Title … Lung Cancerimmune checkpoint inhibitors in oncologyImmunotherapy in Small-Cell Lung CancerInnovative Treatment Strategies for Lung CancerLS …
-
Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer
02 Jul 2025 21:30 GMT
… or metastatic non-small cell lung cancer (NSCLC) with epidermal growth … with non–small cell lung cancer who may be eligible … or metastatic non-small cell lung cancer (NSCLC) with EGFR exon … side effects, skin-related adverse events, ocular toxicity, and the …
-
Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis® LCS
01 Jul 2025 16:21 GMT
… European countries are moving toward lung cancer screening programs implementation, including France … respect to future financial results, events, operations, services, product development … could cause actual results and events to differ materially from …
-
China NMPA approves Hutchmed's Orpathys in combo with Tagrisso to treat lung cancer patients with MET amplification after progression on first─line EGFR inhibitor therapy
01 Jul 2025 08:36 GMT
… non-squamous non-small cell lung cancer (NSCLC) with MET … the complex challenges of lung cancer treatment in China, where … observed. Treatment-emergent adverse events of Grade 3 or above … . Lung cancer is broadly split into NSCLC and small cell lung cancer, …
-
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer
05 Jul 2025 04:04 GMT
… radical cystectomy alone (based on event-free survival [EFS] hazard … alone. Immune-mediated adverse events were consistent with the known … in limited-stage small cell lung cancer (SCLC) based on the … phase III trial.
In lung cancer, Imfinzi is the global …
-
Free air quality monitors which ‘would likely have saved’ boy’s life to be distributed in Dawson Creek
05 Jul 2025 03:55 GMT
… -risk area for wildfire smoke events,” said the press release.
“BC … Emerging Airborne Threats and Heat Events) project.
“All Dawson Creek residents … as asthma, COPD, pulmonary fibrosis, lung cancer and other diseases.
There have …